SE220104C1 - - Google Patents

Info

Publication number
SE220104C1
SE220104C1 SE816760A SE816760A SE220104C1 SE 220104 C1 SE220104 C1 SE 220104C1 SE 816760 A SE816760 A SE 816760A SE 816760 A SE816760 A SE 816760A SE 220104 C1 SE220104 C1 SE 220104C1
Authority
SE
Sweden
Application number
SE816760A
Other languages
Slovenian (sl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of SE220104C1 publication Critical patent/SE220104C1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE816760A 1959-08-26 1960-08-26 SE220104C1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM0042545 1959-08-26

Publications (1)

Publication Number Publication Date
SE220104C1 true SE220104C1 (OSRAM) 1968-04-23

Family

ID=7304374

Family Applications (1)

Application Number Title Priority Date Filing Date
SE816760A SE220104C1 (OSRAM) 1959-08-26 1960-08-26

Country Status (4)

Country Link
CH (1) CH390243A (OSRAM)
FR (1) FR297M (OSRAM)
GB (1) GB951460A (OSRAM)
SE (1) SE220104C1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956349A (en) * 1975-02-18 1976-05-11 Syntex (U.S.A.) Inc. Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof

Also Published As

Publication number Publication date
GB951460A (en) 1964-03-04
CH390243A (de) 1965-04-15
FR297M (fr) 1961-03-13

Similar Documents

Publication Publication Date Title
FI41540B (OSRAM)
AT212261B (OSRAM)
AT219274B (OSRAM)
IT699966A (OSRAM)
AT213532B (OSRAM)
AT219811B (OSRAM)
DE1130183C2 (OSRAM)
AT218043B (OSRAM)
AT219912B (OSRAM)
BE575800A (OSRAM)
BE576809A (OSRAM)
BE576772A (OSRAM)
BE586017A (OSRAM)
BE583329A (OSRAM)
BE584608A (OSRAM)
BE578357A (OSRAM)
CH1168760A4 (OSRAM)
BE579636A (OSRAM)
BE580948A (OSRAM)
NL103394C (OSRAM)
BE579739A (OSRAM)
BE582171A (OSRAM)
BE586050A (OSRAM)
BE582128A (OSRAM)
NL256875A (OSRAM)